Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2008-09-25 13:34:37 UTC |
---|
Update Date | 2022-03-07 02:51:00 UTC |
---|
HMDB ID | HMDB0010621 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | PG(18:1(11Z)/18:3(6Z,9Z,12Z)) |
---|
Description | PG(18:1(11Z)/18:3(6Z,9Z,12Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(18:1(11Z)/18:3(6Z,9Z,12Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the g-linolenic acid moiety is derived from animal fats. Phosphatidylglycerol is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant at up to 11% of the total. It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for diphosphatidylglycerol (cardiolipin). Phosphatidylglycerol is formed from phosphatidic acid by a sequence of enzymatic reactions that proceeds via the intermediate, cytidine diphosphate diacylglycerol (CDP-diacylglycerol). Bioynthesis proceeds by condensation of phosphatidic acid and cytidine triphosphate with elimination of pyrophosphate via the action of phosphatidate cytidyltransferase (or CDP-synthase). CDP-diacylglycerol then reacts with glycerol-3-phosphate via phosphatidylglycerophosphate synthase to form 3-sn-phosphatidyl-1'-sn-glycerol 3'-phosphoric acid, with the release of cytidine monophosphate (CMP). Finally, phosphatidylglycerol is formed by the action of specific phosphatases. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PGs have a net charge of -1 at physiological pH and are found in high concentration in mitochondrial membranes and as components of pulmonary surfactant. PG also serves as a precursor for the synthesis of cardiolipin. PG is synthesized from CDP-diacylglycerol and glycerol-3-phosphate. |
---|
Structure | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C42H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h12-15,18,20,24,26,39-40,43-44H,3-11,16-17,19,21-23,25,27-38H2,1-2H3,(H,47,48)/b14-12-,15-13-,20-18-,26-24-/t39-,40+/m0/s1 |
---|
Synonyms | Value | Source |
---|
1-(11Z-Octadecenoyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-sn-glycero-3-phospho-(1'-glycerol) | HMDB | 1-Vaccenoyl-2-g-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | 1-Vaccenoyl-2-gamma-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | GPG(18:1/18:3) | HMDB | GPG(18:1N7/18:3N6) | HMDB | GPG(18:1W7/18:3W6) | HMDB | GPG(36:4) | HMDB | PG(18:1/18:3) | HMDB | PG(18:1N7/18:3N6) | HMDB | PG(18:1W7/18:3W6) | HMDB | PG(36:4) | HMDB | Phosphatidylglycerol(18:1/18:3) | HMDB | Phosphatidylglycerol(18:1n7/18:3n6) | HMDB | Phosphatidylglycerol(18:1W7/18:3W6) | HMDB | Phosphatidylglycerol(36:4) | HMDB | 1-(11Z-Octadecenoyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-sn-glycero-3-phosphoglycerol | HMDB | PG(18:1(11Z)/18:3(6Z,9Z,12Z)) | Lipid Annotator |
|
---|
Chemical Formula | C42H75O10P |
---|
Average Molecular Weight | 771.0127 |
---|
Monoisotopic Molecular Weight | 770.509785132 |
---|
IUPAC Name | [(2S)-2,3-dihydroxypropoxy][(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy]phosphinic acid |
---|
Traditional Name | (2S)-2,3-dihydroxypropoxy(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxyphosphinic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC |
---|
InChI Identifier | InChI=1S/C42H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h12-15,18,20,24,26,39-40,43-44H,3-11,16-17,19,21-23,25,27-38H2,1-2H3,(H,47,48)/b14-12-,15-13-,20-18-,26-24-/t39-,40+/m0/s1 |
---|
InChI Key | VSRGIKGINQIKBO-FJNFSWOHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphoglycerols |
---|
Direct Parent | Phosphatidylglycerols |
---|
Alternative Parents | |
---|
Substituents | - 1,2-diacylglycerophosphoglycerol
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0085134)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:0) (PathBank: SMP0085147)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0085133)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0085140)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0085141)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0085132)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:1(11Z)) (PathBank: SMP0081821)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:1(13Z)) (PathBank: SMP0081822)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:0) (PathBank: SMP0081823)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:1(13Z)) (PathBank: SMP0081824)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0081827)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)) (PathBank: SMP0081828)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0081829)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0081830)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:1(11Z)) (PathBank: SMP0081832)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:1(13Z)) (PathBank: SMP0081833)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/22:0) (PathBank: SMP0081834)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/22:1(13Z)) (PathBank: SMP0081835)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0081836)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z)/20:1(13Z)) (PathBank: SMP0081837)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z)/22:0) (PathBank: SMP0081838)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0081839)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(13Z)/20:1(13Z)) (PathBank: SMP0081840)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(13Z)/22:0) (PathBank: SMP0081841)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(13Z)/22:1(13Z)) (PathBank: SMP0081842)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/22:0/22:0) (PathBank: SMP0081843)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/22:0/22:1(13Z)) (PathBank: SMP0081844)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0081845)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0085135)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085136)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085137)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085138)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085139)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0085142)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085143)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085144)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085145)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085146)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0085148)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0085149)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085150)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085151)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085152)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0085153)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085154)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085155)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085156)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085157)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085158)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085159)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085160)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085161)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085162)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085163)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085164)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085165)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085166)
- Cardiolipin Biosynthesis CL(18:1(11Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085167)
|
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.73 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 31.2449 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.96 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 77.3 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5542.4 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 311.1 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 323.7 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 220.4 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1141.4 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1778.5 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1099.4 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 238.3 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3271.6 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1177.9 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2859.0 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1273.9 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 726.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 317.8 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 626.6 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 10V, Positive-QTOF | splash10-0hvl-4091721700-b6f4f0d1ed7e2876d692 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 20V, Positive-QTOF | splash10-0hk9-5192422200-cfde55ef80d98c88b668 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 40V, Positive-QTOF | splash10-0adr-9076431100-55977b2b46fe2ff2a1eb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 10V, Negative-QTOF | splash10-02cr-0190100200-30a74687102b24b5fc03 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 20V, Negative-QTOF | splash10-01si-5290200000-4d968e987a887d41aec9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 40V, Negative-QTOF | splash10-004i-9020000000-2e84df79c65aec129d7a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 10V, Negative-QTOF | splash10-014i-0000000900-c28bac06e088565afc8a | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 20V, Negative-QTOF | splash10-017i-0090310400-f55cd4632b5316fab73b | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:1(11Z)/18:3(6Z,9Z,12Z)) 40V, Negative-QTOF | splash10-017i-0190310400-0b48fc7bf8546f2466ba | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|